SELLAS Life Sciences Group, Inc. (SLS) Earnings
|
Expand Research on SLS
| Next EPS Date | 5/9/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -445.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | N/A | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/21/24 | Q423 | N/A | -$0.02 | N/A | N/A | $13M | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.02 | N/A | N/A | $13M | N/A | N/A | N/A | ||
11/9/23  |
Q323 | -$0.33 | $0.02 | -$0.35 | N/A | $13M | N/A |  | | Details | |
| 11/16/23 | Q323 | N/A | $0.02 | N/A | N/A | $13M | N/A | N/A | N/A | ||
| 8/10/23 |
Q223 | -$0.31 | -$0.36 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 8/17/23 | Q223 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | -$0.47 | -$0.29 | -$0.18 | N/A | N/A | N/A | | | Details |
